NPPES file of Aug 9, 2026

Orazio L. Giliberti, MD

Ophthalmology Physician · Totowa, NJ

Orazio L. Giliberti, MD is an ophthalmology physician with a practice address in Totowa, New Jersey, and NPI 1407896475, issued on Jun 7, 2006. Check the license (New Jersey 25MA04637500, as entered in NPPES) on the New Jersey State Board of Medical Examiners; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1407896475
Name
Orazio L. Giliberti
Credential
MD
Primary taxonomy
Ophthalmology Physician 207W00000X
License number
25MA04637500 NJ
Self-reported in NPPES; status is on the state search
Practice location
415 Totowa Road, Totowa, NJ 07512
Phone
(973) 595-0011
Enumerated
Jun 7, 2006
Record last updated
Jul 13, 2026
Fax
(973) 595-5155
Medicare enrollment
Enrolled (PECOS I20050729000143); accepts Medicare assignment
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Verify Orazio L. Giliberti in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersNew Jersey State Board of Medical Examiners
    Search for license 25MA04637500
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the New Jersey license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

49% fewer Medicare Part D claims than the average ophthalmology physician in 2024

778 Medicare Part D claims for 162 beneficiaries, against an average of 1,518 among the 16,459 providers of this specialty who prescribed in Part D. Brand-name drugs were 63% of claims.

  1. Orazio Giliberti778
  2. Specialty average1,518

Most prescribed

  1. Latanoprost70 claims
  2. Restasis62 claims
  3. Timolol Maleate60 claims
  4. Simbrinza52 claims
  5. Xiidra46 claims
  6. Dorzolamide-Timolol41 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

No measured MIPS final score for 2023

CMS assigned the neutral MIPS final score of 75 without scoring Quality, Cost, Promoting Interoperability or Improvement Activities. It is an administrative threshold, so PlainDoctor does not compare it with measured clinicians.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $100.96

6 payments; by number, the most common kind was food and beverage; the largest payer was Bausch & Lomb Americas Inc. The 13,221 providers of this specialty with any payment received $4,535.02 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Orazio Giliberti$100.96
  2. Specialty average$4,535.02

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

3 ophthalmology physician records list a practice address in Totowa

They are 3 of the 242 NPPES records with a practice address in Totowa, and 631 ophthalmology physician records in New Jersey.

Other ophthalmology physician records in New Jersey

  1. Ahmed Abdelhady, MDHolmdel, NJ1467076679
  2. Bryan Abessi, M.D.Branchburg, NJ1104184621
  3. Atul Agarwala, MDIrvington, NJ1427133586
  4. Arlene Ahmad, MDBoonton, NJ1669552881
  5. Adil Ahmed, DOBrick, NJ1003372715
  6. Scott Aksman, MDFreehold, NJ1992886816
  7. Rosemary Albano, MDLong Beach Township, NJ1417565441
  8. Cesar Alfaro Cruz, MDBridgewater, NJ1740712637
  9. Anne Marie Alino, M.D.Paramus, NJ1669417523
  10. Omar Almallah, MDToms River, NJ1376528364

Common questions

What is Orazio L. Giliberti, MD's NPI number?

Orazio L. Giliberti, MD's National Provider Identifier (NPI) is 1407896475, issued on Jun 7, 2006. An NPI identifies a provider in billing; it is not a license.

Where is Orazio L. Giliberti, MD located?

The NPPES record lists a practice address at 415 Totowa Road, Totowa, NJ, 07512. Phone: (973) 595-0011. Providers update this record themselves, so call before visiting.

How can I verify Orazio L. Giliberti, MD's license?

NPPES lists New Jersey license number 25MA04637500, as entered by the provider. Search the New Jersey State Board of Medical Examiners at https://newjersey.mylicense.com/verification/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Orazio L. Giliberti, MD prescribe under Medicare Part D?

In 2024, Orazio L. Giliberti, MD had 778 Medicare Part D claims for 162 beneficiaries; the average among ophthalmology physician prescribers was 1,518. Part D covers Medicare prescriptions only.

What is Orazio L. Giliberti, MD's MIPS final score?

CMS assigned the neutral MIPS final score of 75 for 2023 without scoring any category, so it is not a measured result.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.